Decreased expression of human D-glucuronyl C5-epimerase in breast cancer

International Journal of Cancer

Volumn 122, Issue 5, 2008, Pages 1172-1176

  Grigorieva, Elvira ^a,b   Eshchenko, Tatiana ^a   Rykova, Valentina I ^c   Chernakov, Alexei ^d   Zabarovsky, Eugene ^b   Sidorov, Sergei V ^d  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^d Municipal Central Hospital NI   (Russian Federation)

Author keywords

Breast cancer; D glucuronyl C5 epimerase; Expression; GLCE; Proteoglycan

Indexed keywords

DEXTRO GLUCURONYL C5 EPIMERASE; EPIMERASE; MESSENGER RNA; PROTEOGLYCAN; UNCLASSIFIED DRUG; HEPAROSAN N SULFATE D GLUCURONOSYL 5 EPIMERASE; HEPAROSAN N-SULFATE D-GLUCURONOSYL 5-EPIMERASE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION REGULATION; GLCE GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEOGLYCAN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; CELL TRANSFORMATION; METABOLISM; MIDDLE AGED;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARBOHYDRATE EPIMERASES; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FEMALE; HUMANS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 38749136262     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23203     Document Type: Article

References (21)

1. Timar J, Lapis K, Dudas J, Sebestyen A, Kopper L, Kovalszky I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol 2002;12:173-86.
2. Valla S, Li J, Ertesvag H, Barbeyron T, Lindahl U. Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis. Biochimie 2001;83:819-30.
3. Westergren-Thorsson G, Onnervik PO, Fransson LA, Malmstrom A. Proliferation of cultured fibroblasts is inhibited by L-iduronate- containing glycosaminoglycans. J Cell Physiol 1991;147:523-30.
4. Westergren-Thorsson G, Persson S, Isaksson A, Onnervik PO, Malmstrom A, Fransson LA. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp Cell Res 1993;206:93-9.
5. Syrokou A, Tzanakakis G, Tsegenidis T, Hjerpe A, Karamanos NK. Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship. Cell Prolif 1999;32:85-99.
6. Nikitovic D, Zafiropoulos A, Tzanakakis GN, Karamanos NK, Tsatsakis AM. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions. Anticancer Res 2005;25:2851-6.
7. Tsara ME, Theocharis AD, Theocharis DA. Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin. Anticancer Res 2002;22:2893-8.
8. Theocharis AD, Vynios DH, Papageorgakopoulou N, Skandalis SS, Theocharis DA. Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol 2003;35:376-90.
9. Theocharis AD. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim Biophys Acta 2002;1588:165-72.
10. Skandalis SS, Kletsas D, Kyriakopoulou D, Stavropoulos M, Theocharis DA. The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. Biochim Biophys Acta 2006;1760:1217-25.
11. Skandalis SS, Theocharis AD, Papageorgakopoulou N, Vynios DH, Theocharis DA. The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer. Biochimie 2006;88:1135-43.
12. Li J, Hagner-McWhirter A, Kjellen L, Palgi J, Jalkanen M, Lindahl U. Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem 1997;272:28158-63.
13. Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U. Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem 2001;276:20069-77.
14. Crawford BE, Olson SK, Esko JD, Pinhal MA. Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase. J Biol Chem 2001;276:21538-43.
15. Maccarana M, Olander B, Malmström J, Tiedemann K, Aebersold R, Lindahl U, Li JP, Malmström A. Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. J Biol Chem 2006;281:11560-8.
16. Lindahl U, Bäckström G, Malmström A, Fransson LA. Biosynthesis of L-iduronic acid in heparin: epimerization of D-glucuronic acid on the polymer level. Biochem Biophys Res Commun 1972;46:985-991.
17. Jacobsson I, Lindahl U, Jensen JW, Roden L, Prihar H, Feingold DS. Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. J Biol Chem 1984;259:1056-63.
18. Hagner-McWhirter A, Li JP, Oscarson S, Lindahl U. Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate. J Biol Chem 2004;279:14631-8.
19. Li JP, Gong F, Hagner-McWhirter A, Forsberg E, Abrink M, Kisilevsky R, X. Zhang X, Lindahl U. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 2003;278:28363-6.
20. Li J, Wang F, Protopopov A, Malyukova A, Kashuba V, Minna JD, Lerman MI, Klein G, Zabarovsky E. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene 2004;23:5941-9.
21. Lung HL, Bangarusamy DK, Xie D, Cheung AK, Cheng Y, Kumaran MK, Miller L, Liu ET, Guan XY, Sham JS, Fang Y, Li L et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 2005;24:6525-32.